HistoSonics, Inc.
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2009-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.histosonics.com
Clinical Trials
9
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
- Conditions
- Liver NeoplasmsBenign Liver TumorTumor LiverPrimary Liver CancerSecondary Liver Cancer
- First Posted Date
- 2024-07-03
- Last Posted Date
- 2025-06-08
- Lead Sponsor
- HistoSonics, Inc.
- Target Recruit Count
- 5000
- Registration Number
- NCT06486454
- Locations
- 🇺🇸
Mission Hospital, Mission Viejo, California, United States
🇺🇸AdventHealth Altamonte Springs, Altamonte Springs, Florida, United States
🇺🇸AdventHealth Celebration, Celebration, Florida, United States
The HistoSonics Edison™ System for Treatment of Pancreatic Adenocarcinoma Using Histotripsy
- Conditions
- Pancreatic CancerTumor of PancreasAdenocarcinoma of the PancreasPancreas Cancer
- First Posted Date
- 2024-02-28
- Last Posted Date
- 2025-06-25
- Lead Sponsor
- HistoSonics, Inc.
- Target Recruit Count
- 50
- Registration Number
- NCT06282809
- Locations
- 🇪🇸
Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
The HistoSonics Edison™ System for Treatment of Primary Solid Renal Tumors Using Histotripsy (#HOPE4KIDNEY)
- Conditions
- Renal CancerTumor, SolidTumor, BenignTumorKidney Cancer
- First Posted Date
- 2023-04-19
- Last Posted Date
- 2025-06-11
- Lead Sponsor
- HistoSonics, Inc.
- Target Recruit Count
- 67
- Registration Number
- NCT05820087
- Locations
- 🇺🇸
University of Southern California, Los Angeles, California, United States
🇺🇸University of California, Los Angeles (UCLA), Los Angeles, California, United States
🇺🇸Providence Mission Hosptial, Mission Viejo, California, United States
The HistoSonics Investigational System for Treatment of Primary Solid Renal Tumors Using Histotripsy
- Conditions
- Tumor, BenignTumor, SolidKidney NeoplasmsRenal CancerKidney CancerTumor
- First Posted Date
- 2022-06-27
- Last Posted Date
- 2025-06-25
- Lead Sponsor
- HistoSonics, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT05432232
- Locations
- 🇬🇧
Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
The HistoSonics System for Treatment of Primary and Metastatic Liver Tumors Using Histotripsy (#HOPE4LIVER EU/UK)
- Conditions
- Hepatocellular CarcinomaLiver MetastasesLiver Neoplasms
- First Posted Date
- 2020-10-05
- Last Posted Date
- 2025-06-27
- Lead Sponsor
- HistoSonics, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT04573881
- Locations
- 🇩🇪
Städtisches Klinikum Braunschweig gGmbH, Braunschweig, Germany
🇩🇪Universitätsklinikum Magdeburg Klinik für Radiologie und Nuklearmedizin, Magdeburg, Germany
🇮🇹Istituto Clinico Humanitas - Humanitas Mirasole S.P.A., Milano, Italy
- Prev
- 1
- 2
- Next